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Abstract 
Hyperadrenocorticism is a frequent disease in dogs. The excess of circulating cortisol affects different organs and 
metabolic pathways, producing severe adverse effects that endanger the animal’s life. Among these effects, 
hypertension and renal damage can be mentioned. A group of 20 dogs with pituitary dependent hyperadrenocorticism 
(PDH) and 12 control dogs were used to study the following parameters: cortisol and nitric oxide (NO nit/nit) 
concentrations, diastolic and systolic blood pressure, renal artery resistance index by Doppler ultrasound, the rate of 
glomerular filtration by radio-renogram excretion and the presence of proteins in urine. Dogs with PDH showed a 
significantly lower NO nit/nit (P<0.0001) than the controls and this correlated with high values of diastolic and systolic 
pressure (r = -0.87; P<0.0001 and r = -0.81; P<0.0001 respectively). Most dogs (80%) are hypertensive mainly due to 
an increase in diastolic pressure, which correlated positively with the UPC (r = 0.8; P<0.001) and negatively with the 
glomerular rate of filtration (r = -0.58; P=0.007). Systolic pressure only increased in 60% of the cases and did not 
correlate with the mentioned variables. In PDH the decrease of NO affects blood pressure. The diastolic pressure 
would seem to have the greatest impact on the kidneys, therefore its evaluation and control are important to avoid 
and/or control renal damage. 
Keywords: Blood pression, Hyperadrenocorticism pituitary dependent, Nitric oxide, Renal function, Scintigraphy. 
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Introduction 
Hyperadrenocorticism (HAC) or Cushing syndrome 
(CS) is a frequent disease in dogs characterized by an 
excess of circulating cortisol. This excess affects 
various organs and metabolic pathways, producing 
severe adverse effects that persist even after the disease 
has been controlled (Haentjens et al., 2005; Cabrera 
Blatter et al., 2012).  
Among these adverse effects are high blood pressure 
(HBP) and renal damage (Martiarena et al., 2007; 
Smets et al., 2010, 2012b; Shibata and Fujita, 2012) 
both of which endanger the animal’s life. The reasons 
for HBP due to hyperadrenocorticism are diverse and 
among them, the following stand out: cortisol 
activation of the mineralocorticoids’ receptors (Ulick et 
al., 1992; Funder and Mihailidou, 2009; Shibata and 
Fujita, 2012) alteration of microvascular reactivity, 
endothelial dysfunction, and increase in tone and 
rigidity of the arterial walls (Haentjens et al., 2005; 
Magiakou et al., 2006; Novellas et al., 2008; Lien et al., 
2010; Smets et al., 2010). These effects are related to 
the amount of time with hyperadrenocortisolism before 
its diagnosis and an adequate treatment is established.  
Additionally, this steroid hormone inhibits the nitric 
oxide endothelial synthase enzyme (eNOS), affecting 
nitric oxide (NO) concentrations, which are necessary 
for vasodilatation (Mitchell and Webb, 2002; Yang and 
Zhang, 2004). Previously, our group proved that in 
dogs with pituitary dependent HAC (PDH), NO 
concentrations were decreased and were related to 
circulatory disturbances of the retina artery and vein, 
leading to blindness in dogs with PDH (Cabrera Blatter 
et al., 2011). Around 65% of dogs with HAC have 
HBP, but this percentage can vary according to whether 
only the systolic pressure (SP) or the diastolic pressure 
(DP) is considered (Heaney et al., 1999). On the other 
hand, Lien et al. (2010) discriminated between those 
with PDH and those with an adrenal tumor, reporting 
that in the first, the HBP (evaluating only SP) is present 
in 20% of the cases and that 52.5% of these dogs 
already presented microalbuminuria and 32.5% 
albuminuria, indicative of renal damage. The presence 
of proteinuria together with HBP has also been reported 
by other authors in dogs with HAC (Kubota et al., 
2001; Schellenberg et al., 2008; Wehner et al., 2008; 
Smets et al., 2012b).  
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The kidney is one of the most sensitive organs to an 
increase in blood pressure (Finco, 2004), and HBP is 
one of the most important risk factors involved in 
generating glomerular damage as it leads to alterations 
of glomerular morphology and function, increasing the 
intraglomerular capillary pressure (Lees et al., 2005; 
Wehner et al., 2008; Cianciolo et al., 2016). This favors 
hyperfiltration by the glomeruli, allowing passage of 
albumin and, in time, provoking a deterioration of renal 
function as the filtered protein acts as a nephrotoxic 
agent (Martiarena et al., 2007; Lien et al., 2010). 
Glomeruloesclerosis has been documented in humans 
and in dogs with Cushing Syndrome (Scholz et al., 
1957; Oppenheimer and Esterly, 1963; Ortega et al., 
1996; Waters et al., 1997) and is one of the causes of 
death or of a lower life expectancy. 
The objective of this study was to analyze both arterial 
pressures (diastolic and systolic) and their correlation 
with NO and cortisol concentrations. Furthermore, 
evaluate if there is a correlation between these variables 
and the alteration of the different parameters indicative 
of renal function or health (proteinuria, glomerular 
filtration, renal artery resistance index, urine density). 
Lastly, analyze which of all the above-mentioned 
variables are clinically useful as indicators of incipient 
renal damage.  
Materials and Methods 
Population under study 
Population with PDH 
Twenty dogs with PDH were studied (11 females and 9 
males; of which, 10 were mixed breed, 3 Poodles, 3 
Beagles, 2 Golden Retrievers, 1 Daschund and 1 Pit 
Bull). The age range was between 4 and 15 years old 
(median: 9.9 years) and their weight between 3.1 and 
35 kg (median 11.9 kg). All dogs were diagnosed at the 
Endocrinology Unit of the Teaching Hospital of the 
Faculty of Veterinary Sciences of the University of 
Buenos Aires, where they had been referred by 
colleagues from private practices. 
The dogs showed the characteristic signs of Cushing 
Syndrome: polydipsia, polyuria, polyphagia, thin 
inelastic skin, hair loss, large abdomen, weight gain. 
The diagnosis was confirmed using the 
cortisol:creatinine relationship in urine before and after 
oral administration of dexamethasone (Galac et al., 
1997), ACTH stimulation (basal cortisol measurements 
and 1 h after intravenous administration of 0.25 mg 
ACTH), plasma ACTH measurements, abdominal 
ultrasonography to evaluate the morphology and size of 
the adrenal glands, and Magnetic Resonance of the 
sellar region (Gallelli et al., 2010; Kooistra and Galac, 
2012; Miceli et al., 2014).  
None of these patients had concurrent diseases (heart 
disease, clinically evident kidney disease, urinary 
infections, diabetes mellitus, neoplasia nor systemic 
infectious diseases) nor were they receiving or had 
received treatment for PDH prior to this diagnosis. 
Once diagnosis was carried out and after receiving the 
owner’s written informed consent accepting to allow 
their pet to participate in the study, the planned studies 
were carried out. 
Control population 
A population of 12 healthy dogs (6 neutered females 
and 6 non-castrated males; median age, 6 years old, 
range: 3-10 years) from the Faculty of Veterinary 
Sciences of the Buenos Aires University kennels, on 
whom the same determinations were carried out as on 
the PDH population, save for the radio-renogram 
excretion (by stipulation of the Committee for the Use 
and Care of Laboratory Animals (CICUAL) of the 
Faculty of Veterinary Sciences of the University of 
Buenos Aires), using in this case, standardized values 
from previous studies as a reference. With the aim of 
minimizing changes in the values due to stress, all 
handling for obtaining data was carried out at the dog 
kennel facilities, where the animals were familiar with 
their surroundings. 
Studies 
The procedures described for the PDH population, 
carried out in a specially conditioned area within the 
Teaching Hospital, were carried out in the same way 
for both populations. No sedatives were used, to avoid 
changes in blood pressure or blood flow in the Doppler 
study. The owner was present all the time and in contact 
with their dog.  
Blood pressure measurements 
At the time of consultation, both systolic and diastolic 
blood pressure was measured in all dogs using a high 
definition oscillometric method (VetHDO monitor 
MD/90, Systeme & Beratung, Germany). The 
procedure was carried out after 30 minutes of the 
animal becoming familiar with his surroundings (place, 
voices, stretcher and personnel) and was relaxed. The 
dog was positioned in sternal recumbence on the 
stretcher, a cuff was placed on the left front leg 
(brachial cephalic artery) and 4 consecutive 
measurements were taken so the dog could adapt to the 
pressure of the cuff and the noise of the 
sphygmomanometer during the first measurements. 
The last measurement was taken as the reference value. 
Hypertension was defined as SP ˃ 160 mmHg and/or 
DP ˃ 90 mmHg (Bodey and Michell, 1996; Brown et 
al., 2007). 
Renal Doppler ultrasound study (US-Doppler) 
After measuring blood pressure and thirty minutes prior 
to the study (to recover from the stress of the handling) 
the area of renal projection was shaved and the animal 
was positioned on the stretcher. After resting, gel was 
placed over the area and the study was conducted, 
always by the same operator. The animals were 
positioned in lateral recumbence, both left and right, to 
evaluate the corresponding kidneys using a MINDRAY 
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M5VET equipment, with a micro-convex multi-
frequency 3-7.5 MHZ transducer. First the morphology 
of both kidneys was observed, and if alterations such as 
calcifications, hydronephrosis, cysts, parenchymal 
changes, atrophy or signs of degeneration were noted, 
they were excluded from the study. Subsequently, the 
renal artery resistance index (RI) of each kidney was 
evaluated using the Doppler and a RI ≤ 0.7 was 
considered normal (Morrow et al., 1996; Novellas et 
al., 2007, 2008). 
Radio-renogram excretion in gamma camera 
scintigraphy 
With the aim of evaluating glomerular filtration a 
dynamic scintigraphic study in gamma camera (radio-
renogram excretion) was carried out in a planar gamma 
camera. The radioisotope used was 99m Tc (technetium 
99 metastable sodium pertectneciate, DTPA CaNa3-Sn 
RADIOFARMA® TC, 3-4mCi/111-148 Mbq) at a fixed 
distance of 26 cm over the center of the gamma camera. 
Firstly, static images were taken of the syringes with 
the radiation tracer (before and after intravenous bolus 
injection) and of the patient in lateral recumbence, to 
measure renal depth and subsequently calculate 
glomerular filtration. Afterwards, the animal was 
placed in ventral recumbence and with the gamma 
camera centered dorsal to the kidneys. Dynamic images 
were collected every 15 seconds in a digital 64 x 64 x 
16 mold, for 15 minutes. Sedation of the dogs was not 
necessary to carry out the study. 
Two parameters were determined for this study: 1) the 
rate of glomerular filtration (GFR); 2) the initial 
reactivity time (RT) for each kidney (point at which the 
curve reached the highest activity after implementing 
the radiation tracer, indicating the maximum time for 
glomerular filtration). 
The phases of perfusion, glomerular filtration and 
elimination of the radiation tracer were assessed by 
processing the images and obtaining the glomerular 
function curve. It is considered that for a healthy 
kidney, the GFR should be >3 ml/kg/min and that 
values between 1.2 and 2.7 ml/kg/min and azotemia 
values of <1.2 ml/kg/min are indicative of subclinical 
renal insufficiency. A normal RT is considered to be 
lower than 3.5 minutes, with values higher than 5 
minutes corresponding to kidneys with altered 
function, and intermediate values between 3.6 and 4.9 
minutes, considered suspect (Bartges and Polzin, 
2013). 
Biochemical studies 
Blood and urine samples for all the biochemical studies 
were obtained the day after the aforementioned studies. 
After the serum was obtained from the blood samples 
by centrifugation and stored at -80 ºC until its 
processing, urea, creatinine, total proteins, albumin, 
nitric oxide (NO) and cortisol were evaluated. Blood 
samples were taken after a 12 h fast and collected in 
plastic test tubes without anticoagulant. Urea, 
creatinine, total proteins and albumin were all 
measured in an automated equipment (Metrolab 2100), 
using a standardized enzymatic-colorimetric method 
with specific reagents and according to the 
manufacturer’s indications. 
Urine samples were obtained immediately after blood 
sampling, using a catheter and a sterile jar. A complete 
physical and chemical analysis was carried out, 
considering densities >1025 to be normal for dogs with 
a standard liquid intake and normal urination according 
to their weight, and a quantitative and qualitative 
evaluation of the proteins present was also carried out. 
Protein quantification was accomplished using the 
Protein/Creatinine ratio in urine (UPC), considering 
values lower or equal to 0.3 to be normal, between 0.31 
and 0.49 are suspect and values greater than 0.5 clearly 
pathological (Martiarena et al., 2007). For the 
qualitative determination of proteins, each fraction was 
separated by molecular weight (MW) using a 
polyacrylamide gel in the presence of dodecyl sodium 
sulphate (SDS-PAGE method) with rapid argentum 
coloring. A light band of proteins of 69 kd MW (20 
mg/L) was considered physiological. Bands ≥ 69 kd 
MW were considered indicative of proteins of 
glomerular origin and bands <69 Kd MW were 
considered proteins of tubular origin (Marshall and 
Williams, 1998; Zini et al., 2004; Martiarena et al., 
2007). 
Cortisol and nitric oxide determinations 
Serum cortisol was evaluated using ELISA (“Cortisol 
ELISA, ABCAM”), with an intra and inter assay 
coefficient of variation of 4.8 and 7.8 respectively and 
a sensitivity of 0.4 µg/dL. The reference range obtained 
by our laboratory from a control population was of  
0.8-4.5 µg/dL (median: 2.1 µg/dL). 
NO was measured as previously described by Cabrera 
Blatter et al. (2012), using ELISA (BioVision, EE.UU) 
and calculating the NO production by the nitrites and 
nitrates produced (NO nit/nit). The intra and inter assay 
coefficients of variation were 3.1% and 5.8% 
respectively with a sensitivity of 0.1 nmol nitrites/well. 
The reference range for our laboratory is 3.2 – 7.2 
nmol/mL (median: 5 nmol /mL). 
Statistical analysis 
After carrying out the Pearson Omnibus Normality test, 
and given that most of the variables under study showed 
a non-parametric distribution, the results are expressed 
as median (Mn) and ranges (minimum and maximum 
values) and the medians between the PDH and the 
control groups were compared using the Mann-
Whitney test. Spearman’s test was used to evaluate 
correlation between the different variables and Fisher’s 
Exact test was used to evaluate the existence of an 
association between blood pressure, UPC and the 
resistance of the renal artery, calculating the Odds Ratio 
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(OR) (software GraphPad 6, USA). Significance was 
set at P<0.05. 
Animal welfare  
The Committee for the Use and Care of Laboratory 
Animals (CICUAL) of the Faculty of Veterinary 
Sciences of the University of Buenos Aires approved 
all procedures (Protocol 20720130100004BA) and a 
written consent was obtained from all proprietors for 
carrying out all evaluations and their subsequent 
publication.  
Results 
Blood pressure and renal artery resistance index (RI) 
Eighty percent (16/20) of the dogs studied presented 
diastolic hypertension, with 20% (4/20) showing <90 
mmHg. SP was high (systolic hypertension) in 60% 
(12/20) of the animals and was <160 mmHg in the 
remaining 40% (8/20). All dogs with high SP also had 
a high DP, while of the 8 cases with a normal SP, 5 had 
a high DP. Values of both pressures were significantly 
higher in dogs with PDH as compared to the control 
group (P=0.004 and P=0.002, for SP and DP 
respectively) (Fig.1). 
The RI of the left renal artery was high (Me = 0.68; 
range 0.5-.091) in 40% (8/20) of the cases and the RI of 
the right renal artery was high (Me = 0.71, range 0.57-
0.93) in 50% (10/20) of the cases, without showing 
significant differences between them. In the control 
group, RI was <0.70 in both renal arteries (Me = 0.5, 
range 0.35-0.6), showing significant differences with 
the HAC-PD group (P<0.001). 
Radio-renogram excretion 
No dog presented severe deterioration of renal function, 
although a decrease in kidney mass was observed in 
25% (4/20; 3 of the left kidney and 1 of the right), 
coinciding with affected values of GFR and RT (Fig. 
2). GFR values (Fig. 3) were between 1.2 and 2.7 
ml/kg/min in 35% (7/20) of the dogs and was normal 
(> 3 ml/kg/min) in 65% (13/20) of the dogs. RT was 
altered (>3.5 and <5 minutes) in 35% (7/20) of the 
dogs, coinciding with those in which the GFR was also 
altered (Fig. 3).  
No differences in RT were observed between the left 
and right kidneys. According to the analysis of the 
radio-renogram curves, the phases of glomerular 
filtration and renal perfusion were affected but the 
excretion phase was normal. 
Serum biochemical studies 
Urea, creatinine, total proteins and albumin were within 
the normal reference values in serum for our laboratory 
in all cases (Table 1) and no significant differences 
were found with the control group. Plasma 
concentrations of cortisol were significantly higher 
(P<0.0001) in dogs with PDH (Table 1 and Fig. 4). On 
the other hand, NO nit/nit concentrations were 
significantly lower (P<0.0001) in animals with PDH 
(Table 1 and Fig. 4). 
 
Fig. 1. Systolic (SP) and diastolic (DP) arterial pressure in 
control and PDH dogs. The shaded area indicates the area of 
normal SP and DP arterial pressure. The full line indicates the 
median and each point represents an evaluated dog. (SP: 
**P=0.004 vs. control) (DP: **P=0.002 vs. control). 
 
 
Fig. 2. Data of the gamma camera scintigraphy and radio-
renogram excretion in two dogs with PDH. Upper panel: 
Study within normal parameters. In the figure on the left, the 
glomerular filtration curves (GRF) can be observed; passage 
and excretion, being similar for the evaluation times and the 
RT is also similar (peak of the curve). In the figure on the 
right, both kidneys with equal functional parenchyma uptake 
of the radioisotope can be observed. Bottom panel: Study of 
a dog with affected kidney function. Note that the filtration 
curve and RT are lower than those of the right kidney (see 
explanation in the text) and left kidney (right side) has less 
functional parenchyma (less uptake of the radioisotope). 
 
Urine 
Urine density was significantly lower (P<0.05) in the 
PDH group as compared to the control, with values 
<1025 in 60% of the dogs (12/20) and higher values in 
the remaining 40% of the dogs. All 20 dogs presented 
with polyuria and polydipsia at the time of the study. In 
the control group, urine density was >1025 in the 12 
dogs included in the study. The rest of the physical and 
chemical studies showed no alterations in either group. 
UPC was significantly higher in the PDH group as 
compared to the control, with high values (>0.5) in 55% 
(11/20) of the dogs, unspecific values in 10% (2/20) 
dogs and less than 0.3 in 35% (7/20) (Table 1).  
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Fig. 3. Data of the glomerular filtration rate (GFR) and 
reactivity time in dogs with PDH. The box indicates the 
normal area for GFR and RT. The whole line represents the 
median and each circle is an individual patient that was 
evaluated. 
 
Table 1. Urine density, urea, creatinine and UPC, cortisol and 
NO nit/nit values in control and HAC-PD dogs. 
 
Parameter HAC-PD Control P 
Urea (mg/dL) 
37 
(20-60) 
42 
(30-57) 
NS 
Creatinine 
(mg/dL) 
0.77 
(0.5-1.2) 
0.69 
(0.4-0.9) 
NS 
Total proteins 
(g/L) 
6.8 
(5.7-7.3) 
7.1 
(5.6-7.2) 
NS 
Albumin (g/L) 
3.2 
(2.8-3.3) 
3.1 
(2.9-3.3) 
NS 
Urine density 
1,014 
(1,005-1,038)* 
1,027 
(1,022-1,035) 
<0.05 
UPC 
0.95 
(0.11-5.8)*** 
0.19 
(0.1-0.28) 
<0.0001 
Cortisol 
(µg/dL) 
5.6 
(2.8-10.6)*** 
2.1 
(0.8-4.5) 
<0.0001 
NO nit/nit 
(nmol/mL) 
1.54 
(0.04-3.7)*** 
5 
(3.2-7.2) 
<0.0001 
Values are expressed as median and ranges (minimum and 
maximum). 
 
A 65% (13/20) of the dogs presented glomerular 
proteinuria, coinciding with those presenting high or 
unspecific UPC values. No animal showed proteinuria 
of tubular origin. In the control group, UPC was <0.3 
with no evidence of proteinuria in any of the 12 cases.    
Correlation and association analysis 
Plasma cortisol and NO nit/nit showed a significant 
inverse correlation (r = -0.67; P<0.0001) (Fig. 5). 
SP correlated positively with cortisol (r = 0.46; 
P=0.008) and negatively with NO (r = -0.87; P 
<0.0001) (Fig. 6). No correlation (r = 0.3; P=0.2) nor 
association (P=1.00) was observed between SP and 
UPC. Nor was a correlation observed between SP, the 
renal artery resistance (r = -0.05; P=0.6) and the GFR 
(r = -0.32; P=0.16).  
DP correlated positively with plasma cortisol (r = 0.63; 
P<0.0001) and inversely with NO nit/nit (r = -0.81; 
P<0.0001) (Fig. 6).  
 
Fig. 4. Plasma cortisol and NO nit/nit concentrations in 
control dogs and in dogs with PDH. Each circle represents a 
dog, open circles and triangles: controls and filled-in circles 
and triangles: dogs with PDH; the full line represents the 
median. *** P<0.0001, PDH vs. controls. 
 
 
Fig. 5. Correlation between NO nit/nit and plasma cortisol. 
Note that the 12 control dogs have the highest NO nit/nit 
values (top left quadrant) to then decrease as the cortisol 
concentrations increase. 
 
Correlation was also observed with UPC (r = 0.8; P 
<0.001) (Fig. 7), and a significant association (P <0.05) 
was found between the presence of proteinuria and a 
high DP, with an OR of 0.08 (95%CI: 0.01-0.63). No 
significant correlation was seen between DP and the 
renal artery resistance index (r = 0.35; P=0.16), and DP 
showed a negative correlation with GFR (r = -0.58; 
P=0.007) (Fig. 6). The RI correlated positively with 
plasma cortisol (r = 0.69; P=0.0007) and negatively 
with NO nit/nit (r = -0.53, P=0.014) (Fig. 8). The 
increase in RI coincided with an increase in DP in 10/20 
dogs, however no statistically significant association 
was observed between these parameters (P=0.36). 
Regarding SP, 40% (8/20) of the dogs coincided in 
having both parameters altered, though this association 
was not significant either (P=0.36). No correlation was 
observed between RI and UPC (r = 0.2; P=0.8), 
although these parameters did show a statistical 
association (P <0.01), where all 11 dogs with UPC >0.5 
and the two dogs with unspecific values had a RI >0.7, 
with an OR of 0.017 (95% CI: 0.001-0.41). Correlation 
was found between NO nit/nit and GFR (r = -0.34; 
P=0.14). 
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Fig. 6. Correlation between the systolic and diastolic 
pressures and plasma cortisol (A) and with NO nit/nit (B). It 
can be seen how the diastolic pressure is the most affected by 
the cortisol concentrations (A), contrary to what happens with 
the NO nit/nit (B), where both arterial pressures are similarly 
affected. 
 
 
Fig. 7. Correlation between UPC (A) and GFR (B) with 
diastolic pressure. The elevated presence of proteins in urine 
in the PDH clearly coincides with high diastolic values (A). 
The glomerular filtration rate is also affected by the diastolic 
pressure (B), although to a lesser degree given the correlation 
values. 
 
Fig. 8. Correlation between the RI vs. plasma cortisol (A) and 
NO nit/nit (B).  Evidently the alteration of this index in the 
PDH is influenced mainly by the cortisol concentrations (A) 
and to a lesser degree by the NO (B) as shown by the 
correlation values. 
 
Finally, GFR did not show correlation with cortisol (r 
= -0.16; P=0.5), although the aforementioned hormone 
correlated with NO nit/nit (r = 0.54; P=0.004). 
Discussion 
Among the adverse effects of the chronic 
hypercortisolism of PDH is HBP and, as a 
consequence, renal glomerular dysfunction. Studies in 
human medicine have shown that these adverse effects 
persist even after reaching normal cortisol 
concentrations (Haentjens et al., 2005), coinciding with 
studies in dogs (Martiarena et al., 2007; Smets et al., 
2012a), thus early identification is important to 
implement adequate preventive or therapeutic 
measures.  
In the first place, it is necessary to analyze the behavior 
of NO nit/nit in PDH as it is one of the triggering factors 
for HBP and glomerular damage, together with and 
because of the excess cortisol. As plasma cortisol 
concentrations increase, NO nit/nit descends, a fact 
which has already been reported both in dogs and in 
humans with Cushing syndrome (Wen et al., 2000; 
Cabrera Blatter et al., 2012) and is because of the 
inhibition of eNOS (Magiakou et al., 2006). Therefore, 
the descent of NO in PDH, together with other 
proposed mechanisms (Haentjens et al., 2005; 
Magiakou et al., 2006; Novellas et al., 2008; Lien et al., 
2010; Smets et al., 2010), would be one of the causes 
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of HBP, as evidenced by the strong correlation 
observed between NO nit/nit and both blood pressures. 
Various authors refer that between 20 and 86% of dogs 
with PDH have high blood pressure (Ortega et al., 
1996; Hurley and Vaden, 1998; Novellas et al., 2008; 
Lien et al., 2010), considering one or both types of 
blood pressure and the method of measuring them.  
In this study, where both arterial pressures were 
evaluated, 80% of the dogs had hypertension and the 
DP was a determining factor in this. It is noteworthy 
that this pressure was the only one that was elevated in 
20% of the animals studied, with a normal SP. We did 
not observe the inverse situation: high SP with normal 
DP. If only SP had been taken into consideration, only 
60% of the dogs would have been hypertensive, hence 
it is very probable that its increase is later on, as the 
disease progresses and more vasodilator mechanisms 
are affected (Novellas et al., 2008; Wehner et al., 2008) 
and for this reason, in addition to the evaluation method 
used and that SP was the only pressure measured, Lien 
et al. (2010) reported only 20% as being hypertensive.  
Although both blood pressures correlated with NO 
nit/nit, when analyzing their correlation with cortisol, 
we see that the impact of the hormone is greater on the 
DP than on SP. Therefore, one could assume that DP 
would be affected earlier and to a greater extent than 
the systolic, by the combined action of the excess of 
cortisol and the descent of NO, thus one could consider 
that dogs with PDH are eminently diastolic 
hypertensive. 
Diastolic hypertension was associated with the 
presence of proteinuria, evaluated using UPC (an 
indicator of glomerular damage), showing correlation 
between these parameters and becoming a risk factor. 
It also showed an association and correlated with the 
decrease in GFR. We have not found any other similar 
reports in dogs. Wehner et al. (2008) found a 
correlation between UPC and SP in dogs affected by 
several diseases that produce hypertension without 
differentiating diseases (mentioning only two cases 
with endocrine pathology), and without evaluating DP.  
In this study, we only analyzed dogs with PDH, hence 
our findings cannot be made extensive to cases of 
adrenal tumors or other endocrine pathologies. Due to 
all the above, it is important to take into consideration 
the DP, as if it is not rapidly controlled, its increase will 
start to damage the glomeruli, allowing filtration of 
high molecular weight proteins and affecting the rate of 
glomerular filtration (Lees et al., 2005; Wehner et al., 
2008; Cianciolo et al., 2016). Given the correlation 
between both blood pressures with cortisol and NO 
nit/nit, and of DP with UPC and GFR, it is to be 
expected that dogs recently diagnosed with PDH are 
already hypertensive and have some degree of 
glomerular damage. Suspicion of renal glomerular 
damage is reinforced by the findings in the RI of the 
renal artery. This index was found to be altered in 40-
50% of the cases (according to the kidney evaluated) 
and correlated with cortisol and NO nit/nit, but not with 
the blood pressures. Excess cortisol increases the renal 
vascular resistance in both in humans and dogs with 
HAC (Magiakou et al., 2006; Smets et al., 2010). In 
addition, both cortisol and NO will affect the renal 
artery by the previously discussed mechanisms. In 
human medicine, Ingaramo (2003) report a correlation 
between RI and systolic but not diastolic pressure, 
however our results only coincide regarding the lack of 
correlation with DP and differ in that in dogs SP did not 
correlate either, hence this needs further study.  Fifty 
percent of the dogs with diastolic and systolic 
hypertension had an elevated RI, so presumably in 
these cases there already is an important amount of 
damage to the renal parenchyma and the internal 
vasculature (Morrow et al., 1996; Petersen et al., 1997; 
Novellas et al., 2008). It is probable that renal 
parenchyma is progressively affected according to the 
amount of time of evolution of PDH and the untreated 
hypertension; hence, with an RI <0.7, renal damage 
should not be discarded and is indicative that the kidney 
can still recuperate. On the contrary, RI >0.7 values 
associated with HBP and UPC>0.5, have a reserved 
prognosis (Wehner et al., 2008). 
This slow but progressive evolution toward renal 
damage would explain the association between RI and 
UPC but that they are uncorrelated. Prior to detection 
of high molecular weight proteins (analyzed by UPC) 
microalbuminuria can already be detected due to the 
incipient glomerular damage (De Jong and Gansevoort, 
2009; Lien et al., 2010). This microfiltration of proteins 
slowly affects renal parenchyma (Martiarena et al., 
2007; Shibata and Fujita, 2012), however, it is still not 
enough to be reflected in the US-doppler studies (as the 
RI<0.7) nor by the radio-renogram excretion (as GFR 
>3ml/kg/min). Due to methodological reasons, we did 
not study the microalbuminuria in this study, so there 
are probably a larger number of affected individuals. 
According to the study by Lien et al. (2010), 
microalbuminuria is present in 52.5% of dogs with 
PDH, hence one should consider that at the moment of 
evaluating RI and UPC there already is glomerular and 
renal parenchyma damage in dogs with PDH. In the 
present study, 65% of the cases had a UPC value >0.3, 
jointly considering those with unspecific UPC (10%) 
and those with values >0.5 (55%), with albumin of 
glomerular origin being the predominant protein 
present according to the electrophoretic urine 
proteinogram (Martiarena et al., 2007) and in addition 
the dogs presenting hypertension. These data contrast 
with those of Lien et al. (2010) for whom only 32.5% 
of the dogs show albuminuria, indicating a more 
advanced stage of glomerular damage. This 
discrepancy could be, on the one hand, because the 
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animals in both studies were at different stages of 
evolution of PDH (longer in our case) and, on the other 
hand, if we consider the microalbuminuria, the data are 
similar, hence UPC and the electrophoretic 
proteinogram with SDS-PAGE would be including the 
microalbuminuria in the case of the dog. To summarize, 
in the case of diastolic hypertension and UPC with 
values already higher than 0.3, it is highly probable that 
the glomerulus is compromised and it is advancing 
toward parenchymal damage. In these cases, the RI 
value will be of use as an indicator of the state of the 
kidney parenchyma. 
Regarding the radio-renogram excretion, no dog 
presented severe functional deterioration, although in 
25% one kidney was more affected than the other. As 
mentioned before, GFR was inversely affected by the 
NO nit/nit concentrations. Possibly as a reflection of the 
lower vasodilation of the afferent and efferent small 
arteries, provoking a decrease in renal plasmatic flow 
(Denton et al., 2001). Although administration of 
glucocorticosteriods increases GFR in the short term 
(Wen et al., 2000), chronic exposition, as is the case of 
HAC, provokes the opposite effect (Haentjens et al., 
2005; Smets et al., 2010) as there is a long-term 
counter-productive effect of cortisol on GFR that 
persists even in HAC individuals in remission. 
Considering that most (65%) of the dogs studied 
presented a normal GFR, despite already showing 
proteinuria and an affected RI, this would indicate that 
filtration is not affected early on and that the polyuria 
typical of PDH would not be due to a greater filtration, 
but mainly because the vasopressin hormone is affected 
(Baas et al., 1984; Knoepfelmacher et al., 1997). Both 
GFR and RT did not correlate with cortisol (at least 
directly) and this could be explained by the hypothesis 
postulated by Haentjens et al. (2005). Our study 
evaluated cortisol, GFR and RT at a precise moment in 
time and not prospectively, a fact which could explain 
the lack of correlation. Regarding the other indicators 
of renal function that were analyzed (urine density, urea 
and creatinine) Feldman and Nelson (2004) describe in 
dogs with HAC that 85% present urine densities <1020. 
Our data are close to this value (60% of the cases). The 
fact that urine density is not noticeably low (<1010), 
despite the polyuria-polydipsia, should be attributed to 
the important proteinuria observed. It is necessary to 
highlight that the concentrations of urea and creatinine 
were within the reference range for our laboratory, 
coinciding with data published by Feldman and Nelson 
(2004) in dogs with PDH. These authors postulate that 
it could be due to subclinical states of renal disease, as 
urea and creatinine concentrations increase when the 
disease is more advanced. Our observations in the 
radio-renogram excretion study would explain the 
normal urea and creatinine concentrations and support 
Feldman and Nelson’s hypothesis. 
Conclusions 
It is clear that PDH hypercortisolism leads, firstly, to 
the decrease of NO, which affects the diastolic pressure 
before the systolic, being eminently a diastolic 
hypertension.  The hypertension together with the 
excess of cortisol progressively damage the glomeruli 
and the renal parenchyma, resulting in the presence of 
proteins in urine, alteration of RI and finally the 
decrease of GFR and increase of RT, affecting, in some 
cases, the functional mass of one or both kidneys. 
Thus, measuring diastolic arterial pressure together 
with RI and UPC are the earliest indicators of 
glomerular damage which, if not treated, end in renal 
function being greatly affected.  
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